Publications by authors named "Xavier Preville"

Claim this Profile
E
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors.
Marc Lopez, Emerence Crompot, Emmanuelle Josselin, Anne Farina, Marion Rubis

Cancer Res Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies.
Anne Rogel, Fathima M Ibrahim, Stephen M Thirdborough, Florence Renart-Depontieu, Charles N Birts, Xavier Preville

JCI Insight· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated IL-6/IL-1Ra ratio as a prognostic biomarker of poor chemotherapy efficacy in Chinese patients with metastatic NSCLC, validated in a Caucasian patient cohort.
Fang Liu, Benoît Sansas, Xavier Préville, Romain Gineste, Jialei Wang

Mol Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model.
Christelle Remy-Ziller, Christine Thioudellet, Julie Hortelano, Murielle Gantzer, Virginie Nourtier

Hum Vaccin Immunother· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC.
Caroline Tosch, Bérangère Bastien, Luc Barraud, Benoit Grellier, Virginie Nourtier

J Immunother Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy.
Laetitia Fend, Takahiro Yamazaki, Christelle Remy, Catherine Fahrner, Murielle Gantzer

Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Typing of killer-cell immunoglobulin-like receptors and their cognate human leukocyte antigen class I ligands predicts survival of Chinese Han patients with metastatic non-small-cell lung cancer.
Hui Yu, Fang Liu, Benoit Sansas, Bin Kang, Xavier Preville

Mol Clin Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors.
Emmanuelle Schaedler, Christelle Remy-Ziller, Julie Hortelano, Nadine Kehrer, Marie-Christine Claudepierre

Vaccine· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition.
Patricia Kleinpeter, Laetitia Fend, Christine Thioudellet, Michel Geist, Nathalie Sfrontato

Oncoimmunology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial Watch-Oncolytic viruses and cancer therapy.
Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Xavier Preville

Oncoimmunology· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand.
Xavier Préville, Karola Rittner, Laetitia Fend

Oncoimmunology· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous injection of MVA virus targets CD8+ lymphocytes to tumors to control tumor growth upon combinatorial treatment with a TLR9 agonist.
Laetitia Fend, Tanja Gatard-Scheikl, Jacqueline Kintz, Murielle Gantzer, Emmanuelle Schaedler

Cancer Immunol Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
Myew-Ling Toh, Jean-Yves Bonnefoy, Nathalie Accart, Sandrine Cochin, Sandy Pohle, Xavier Preville

Arthritis Rheumatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.
Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, Kariman Chaba, David P Enot

Nat Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial Watch:: Oncolytic viruses for cancer therapy.
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Xavier Preville

Oncoimmunology· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.
Hélène Haegel, Christine Thioudellet, Rémy Hallet, Michel Geist, Thierry Menguy, Xavier Preville

MAbs· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts.
Laetitia Fend, Nathalie Accart, Jacqueline Kintz, Sandrine Cochin, Carine Reymann

PLoS One· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapy.
Marie-Christine Claudepierre, Julie Hortelano, Emmanuelle Schaedler, Patricia Kleinpeter, Michel Geist, Xavier Preville

J Virol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological characterization of a modified vaccinia virus Ankara vector expressing the human papillomavirus 16 E1 protein.
Christelle Remy-Ziller, Claire Germain, Anita Spindler, Chantal Hoffmann, Nathalie Silvestre

Clin Vaccine Immunol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy.
Laurent Amiset, Laetitia Fend, Tania Gatard-Scheikl, Karola Rittner, Vanessa Duong

Oncoimmunology· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving administration regimens of CyaA-based vaccines using TRAP assays to detect antigen-specific CD8(+) T cells directly ex vivo.
Sandrine Daubeuf, Xavier Préville, Marie Momot, Yolande Misseri, Etienne Joly

Vaccine· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical labels metabolically installed into the glycoconjugates of the target cell surface can be used to track lymphocyte/target cell interplay via trogocytosis: comparisons with lipophilic dyes and biotin.
Sandrine Daubeuf, Anne Aucher, Srinivasa-Gopalan Sampathkumar, Xavier Preville, Kevin J Yarema

Immunol Invest· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system.
Pedro Berraondo, Clémence Nouzé, Xavier Préville, Daniel Ladant, Claude Leclerc

Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A very rapid and simple assay based on trogocytosis to detect and measure specific T and B cell reactivity by flow cytometry.
Anne-Laure Puaux, Julie Campanaud, Audrey Salles, Xavier Préville, Benedikt Timmerman

Eur J Immunol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis